Showing 13,041 - 13,060 results of 69,060 for search '(( 5 ((we decrease) OR (mean decrease)) ) OR ( 100 ((nn decrease) OR (a decrease)) ))', query time: 1.49s Refine Results
  1. 13041
  2. 13042
  3. 13043
  4. 13044
  5. 13045
  6. 13046
  7. 13047

    HCV-NS5A protein mediates TGFβ-induced downmodulation of NKG2D. by Damien Sène (237641)

    Published 2010
    “…B) NS5A-mediated decrease in NK cell lytic potential. …”
  8. 13048

    Identification of optimal 8-mer and 9-mer peptide epitopes. by Mariah Hassert (5746874)

    Published 2020
    “…Five days post boosted infection with SARS-CoV-2 following transfection with hACE2 mRNA, splenocytes were harvested and stimulated for 6 hours with each peptide in the presence of brefeldin A. …”
  9. 13049

    Analysis of CFSE-stained A375 cells treated with leflunomide confirms an AhR-dependent effect on proliferation. by Edmond F. O’Donnell (315794)

    Published 2013
    “…<p>A375-pTRIPZ-shAhR cells with or without DOX induced-AhR knockdown were stained with CFSE and treated with vehicle (DMSO 0.1% v/v), 1 nM TCDD, or leflunomide at 20, 50, and 100 µM for 72 hours followed by flow cytometry. …”
  10. 13050

    Putative reorganization of conserved structures within the HCV genome over time. by Brendan A. Palmer (3361331)

    Published 2016
    “…(B) L1a dominant sequence motif from sample 8. Whereas the mutations observed led to an overall decrease in the minimum free energy of the structure, it is the cumulative contribution of mutations across the length of the amplicon that determine overall stability. …”
  11. 13051

    Image 1_5-deoxy-rutaecarpine protects against LPS-induced acute lung injury via inhibiting NLRP3 inflammasome-related inflammation.pdf by Jinque Luo (9645983)

    Published 2025
    “…NLRP3 inflammasome-driven inflammation is essential in ALI pathogenesis, inspiring novel therapeutic strategies that focus on NLRP3 and inflammation. In this study, we investigated the therapeutic potential of 5-deoxy-rutaecarpine (5-DR), a rutaecarpine derivative, in attenuating LPS-induced ALI.…”
  12. 13052

    Data Sheet 1_5-deoxy-rutaecarpine protects against LPS-induced acute lung injury via inhibiting NLRP3 inflammasome-related inflammation.pdf by Jinque Luo (9645983)

    Published 2025
    “…NLRP3 inflammasome-driven inflammation is essential in ALI pathogenesis, inspiring novel therapeutic strategies that focus on NLRP3 and inflammation. In this study, we investigated the therapeutic potential of 5-deoxy-rutaecarpine (5-DR), a rutaecarpine derivative, in attenuating LPS-induced ALI.…”
  13. 13053

    Table 1_5-deoxy-rutaecarpine protects against LPS-induced acute lung injury via inhibiting NLRP3 inflammasome-related inflammation.docx by Jinque Luo (9645983)

    Published 2025
    “…NLRP3 inflammasome-driven inflammation is essential in ALI pathogenesis, inspiring novel therapeutic strategies that focus on NLRP3 and inflammation. In this study, we investigated the therapeutic potential of 5-deoxy-rutaecarpine (5-DR), a rutaecarpine derivative, in attenuating LPS-induced ALI.…”
  14. 13054
  15. 13055

    Current working model for the link between malonate and virulence gene expression in <i>V. cholerae</i>. by Yusuke Minato (263245)

    Published 2013
    “…<p>Malonate is possibly imported by one of the Auxin Efflux Carrier (AEC) Family proteins (VC1229 and VCA0024). We propose that increased levels of malonyl-CoA decrease the available intracellular CoA levels which results in decreased acetyl-CoA (AcCoA) levels. …”
  16. 13056

    Comparing Theoretical and Experimental DNA Damage Pattern along 1 GeV/amu Fe Track by Sylvain V Costes (33328)

    Published 2013
    “…Measuring the correlation between theoretical and experimental distributions, we observe a decrease of correlation between these two time points, from 0.6 to 0.45. …”
  17. 13057
  18. 13058
  19. 13059
  20. 13060

    Nutritional treatment with an immune-modulating enteral formula alleviates 5-fluorouracil-induced adverse effects in rats by Kentaro Nakamura (178769)

    Published 2019
    “…Here, we investigated whether nutritional treatment with the IMF could prevent 5-fluorouracil (5-FU)-induced adverse effects in rats. …”